Galectin-3 levels and outcomes after myocardial infarction: a population-based study

R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the American …, 2019 - jacc.org
Abstract Background: Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association
with adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose …

[HTML][HTML] Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study

R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the American …, 2019 - Elsevier
Abstract Background Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association
with adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose …

[HTML][HTML] Galectin-3 Levels and Outcomes after Myocardial Infarction: A Community Study

R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the …, 2019 - ncbi.nlm.nih.gov
BACKGROUND: Galectin-3 (Gal-3) is implicated in cardiac fibrosis but its association with
adverse outcomes after myocardial infarction (MI) is unknown. OBJECTIVES: To examine …

Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study

R Asleh, M Enriquez-Sarano… - Journal of the …, 2019 - mayoclinic.elsevierpure.com
Background: Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association with
adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose of …

[引用][C] Galectin-3 Levels and Outcomes After Myocardial Infarction

R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the American …, 2019 - cir.nii.ac.jp

Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study

R Asleh, M Enriquez-Sarano… - Journal of the …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association with
adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose of …

Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.

R Asleh, M Enriquez-Sarano, AS Jaffe… - Journal of the …, 2019 - europepmc.org
Background Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association with
adverse outcomes after myocardial infarction (MI) is unknown. Objectives The purpose of …

Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study

R Asleh, M Enriquez-Sarano… - Journal of the …, 2019 - mayoclinic.pure.elsevier.com
Background: Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association with
adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose of …